Further study has indicated that yuanhuacine (30) could also be anticancer bioactive against H1993 human non-small cell lung cancer (NSCLC) cells both in vitro and in vivo by modulation of the AMPK/mTOR signaling pathway [105]. Here, MTOR is linked to non-small cell lung carcinoma.